Seminars in Oncology
Volume 35, Issue 2 , Pages 100-107, April 2008

Current Neurosurgical Management of Brain Metastases

  • David W. Andrews

      Affiliations

    • Corresponding Author InformationAddress correspondence to David W. Andrews, MD, 909 Walnut St, 2nd Floor, Thomson Jefferson University, Jefferson Medical College, Philadelphia, PA 19107.

Department of Neurosurgery, Thomson Jefferson University, Jefferson Medical College, Philadelphia, PA.

Brain metastases occur in a third of patients diagnosed with cancer; without any intervention, the prognosis is quite poor with a median survival of 1 month. Because of the constraints of the blood-brain barrier, chemotherapy is not effective and treatment options include surgery, whole brain radiation, or stereotactic radiation. This chapter is devoted to a review of the current management options for treatment of brain metastases.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(07)00272-2

doi:10.1053/j.seminoncol.2007.12.003

Seminars in Oncology
Volume 35, Issue 2 , Pages 100-107, April 2008

Article Tools

* Image Usage & Resolution